Displaying items by tag: Concurrent Session

7:00 AM - 8:00 AM Saturday, January 15

Neuromodulation and Neurosurgical Mentorship and Educational Development

The fields of neuromodulation and neurosurgery are under constant change, with the regular introduction of new devices and techniques. As the educational and training background of residents and fellows is quite diverse, this necessitates a unified platform to provide trainees with education and professional development. This session highlights the development of mentorship building programs for pain practitioners and neurosurgeons, with a discussion on improving the learning curve and technical proficiency of common procedures.

Speaker:

Michael D. Staudt, MD

Steven M. Falowski, MD

Sharona Ben-Haim, MD

Thomas P. Pittelkow, DO MPH

Vibhor Krishna, MD SM

Holger Joswig

7:00 AM - 8:00 AM Saturday, January 15

Controversies in Targeted Drug Delivery

Intrathecal drug delivery is a well-established intervention for chronic pain and severe spasticity with over 3 decades of clinical use. Safe and effective utilization of this technique requires solid technical skills. The purpose of this course will be to describe the subtleties and controversies regarding intrathecal drug delivery. Multiple medical specialists would find this course of interest including neurology, neurosurgery, anesthesiology and physical medicine and rehabilitation. This course will also be of interest to many allied health professionals such as physical therapy, occupational therapy, nursing, pharmacy, case management and bioengineering.

Speaker:

Michael F. Saulino, MD PhD

Erik Shaw, DO

Jay S. Grider, DO PhD MBA

Kimberly Heckert, MD

Jonathan M. Hagedorn, MD

7:00 AM - 8:00 AM Saturday, January 15

Accelerating Non-Pain Physician Awareness of the Role of Neuromodulation: A Discussion in Healthcare Delivery Science

While significant advancements in neuromodulation have created to improved patient outcomes for an expanded number of painful conditions, conditions that may be managed primarily by non pain specialists. The limited implementation and uptake of these treatments by referring providers in non-pain care specialties impacts patient access to these high impact treatments. Illustrating the gaps and barriers that impact access enables strategic development aimed at accelerating uptake of these treatments at the population and health care ecosystem level.

Speaker:

Ramana K. Naidu, MD

David Dickerson, MD

Maricela Schnur, MD MBA

Johnathan H. Goree, MD

Dawood Sayed, MD

10:30 AM - 12:00 PM Saturday, January 15

Spinal Cord Stimulation Mechanisms: Results from Animal Studies

Spinal cord stimulation (SCS) mediates analgesia by modulating spinal cord circuits. Multiple lines of evidence obtained from animal models suggest that SCS augments inhibition, decreases excitability, and reverses pathological states. This session will cover the latest research describing the effects of SCS on spinal networks

Speaker:

David L. Cedeno, PHD

Christy Hunt, DO

Andrei Sdrulla, MD PhD

Antonietta Canna, PhD

Ilona Obara, PhD

Yun Guan, MD, PhD

10:30 AM - 12:00 PM Saturday, January 15

Innovations in Patient and Provider Education to Improve Access to Neuromodulation

Despite recent advances in the scope and breadth of neuromodulation treatments, often times access continues to be limited. Many referring providers are not knowledgeable about the treatments available and many patients, especially those in underserved and rural communities, are statistically undertreated. During this session, we will discuss innovations in education both of neuromodulators, front line providers, and patients in hopes to increase global access to new, groundbreaking neuromodulation therapies.

Speaker:

Johnathan H. Goree, MD

Stephanie G. Vanterpool, MBA MD

Parag G. Patil, MD PhD

Eric G. Cornidez, MD MBA

Jaleesa Jackson, MD

Geetha Mahendran

10:30 AM - 12:00 PM Saturday, January 15

New Targets and Paradigms for Psychiatric Neuromodulation

Within psychiatry, neuromodulation has mainly been explored using a small group of intracerebral targets. This session explored some of the other psychiatric conditions for which neuromodulation is being studied with emphasis on new neuroanatomic targets and new therapy selection.

Speaker:

Cameron McIntyre, PhD

Damian S. Shin, PhD

Roscoe Brady

Kelly R. Bijanki, PhD

Francis Bambico, MD

Jon T. Willie, MD PhD

10:30 AM - 12:00 PM Saturday, January 15

Brain Neuromodulation - Where Is the Evidence for What We Do? (CNS Session)

The accepted indications for brain neuromodulation are growing. However, what is the quality of the scientific evidence behind the current clinical uses of brain neuromodulation? This session will explore the extant level of evidence behind brain neuromodulation for a variety of neurologic disorders

Speaker:

Julie G. Pilitsis, MD PhD

Nader Pouratian, MD PhD

Ellen L. Air, MD PhD

Nathan Rowland

Sharona Ben-Haim, MD

Heather Pinckard-Dover, MD

7:00 AM - 8:00 AM Friday, January 14

Connecting with the Future: Neuromodulation Art and Science Made Easy with Technology

In the era of significant technological advances not only in neuromodulation but also in day to day activities, teaching and learning complex tasks need to be aligned with the times. As such, classical techniques of classroom teaching as well as direct hands on teaching may be challenged with new modalities involving virtual reality, simulation, social media and beyond. Exploring all those techniques as well as reinventing classic learning techniques such as PBLD's, flopped classes and others this session will give participants tools to navigate and retain information and sources in the complex field of neuromodulation

Speaker:

Meredith Barad

Nebojsa Nick N. Knezevic, MD PHD

Maged N. Guirguis, MD

Sayed E. Wahezi, MD

Magdalena M. Anitescu, MD PhD

Kiran V. Patel, MD

Log in